A nurse checks an NPH insulin product before administration. What is its usual insulin action category?
2 Insulin Safety Online Quiz Questions
Use this free practice quiz with 20 questions to review 2 Insulin Safety, test your knowledge, and prepare for your next test or exam.
A nurse proposes sharing an insulin pen with another patient after changing the needle. Is this safe?
- A
True
- B
False
Errors in insulin type, concentration, dose, timing, or route can cause .
A nurse is comparing usual meal-related timing for regular insulin and rapid-acting insulin. Which statement is accurate?
- A
Regular insulin is rapid-acting and is generally given at the same time as a meal.
- B
Regular insulin is short-acting and is generally given earlier before a meal than rapid-acting insulin.
- C
Regular insulin is long-acting basal insulin with no pronounced peak.
- D
Regular insulin is intermediate-acting and is usually cloudy.
An alert patient with a glucose of 62 mg/dL can swallow safely. According to the described initial response, how much fast-acting carbohydrate should be given?
A nurse should rely only on a memorized insulin schedule because insulin action times do not vary by product or person. Is this statement true or false?
- A
True
- B
False
An order says “insulin 12 units subcutaneously,” and the available supply includes a U-100 vial and a U-500 pen. What is the safest action?
- A
Choose either product because the prescribed dose is in units.
- B
Use the U-500 pen and give 12 units.
- C
Verify the exact insulin product and concentration against the order or prescriber before administering.
- D
Convert the prescribed units to milliliters and use either product.
A patient has a prescribed rapid-acting insulin dose with lunch, but the meal tray is delayed. What is the safest action?
- A
Give the full dose immediately so it is not late.
- B
Coordinate the dose with meal availability and follow the order and facility protocol; seek clarification if timing or intake is uncertain.
- C
Give the dose and ask the patient to wait for the meal.
- D
Replace the mealtime dose with long-acting insulin.
An alert patient can swallow safely and has hypoglycemia. Select all actions consistent with the described initial treatment and follow-up.
- A
Give 15 g of fast-acting carbohydrate to an alert person who can safely swallow.
- B
Recheck glucose in 15 minutes.
- C
Repeat treatment if glucose is still below 70 mg/dL, following facility protocol.
- D
Give a high-fat snack and do not recheck glucose.
- E
Give oral food or drink even if the patient becomes unable to swallow.
Which inpatient glucose-monitoring plan best reflects common practice for patients with different eating status and insulin treatment?
- A
Check only at bedtime, regardless of meals or insulin route.
- B
For a patient eating, check before meals; if not eating, check every 4–6 hours as ordered; follow protocol for more frequent checks with intravenous insulin.
- C
Check only when the patient reports symptoms.
- D
Use the same monitoring frequency for every patient and insulin regimen.
A patient with type 1 diabetes is NPO for a procedure. Select all components of a safe insulin plan.
- A
Verify the individualized plan because basal insulin is generally still needed for a person with type 1 diabetes.
- B
Discontinue all insulin until the patient eats.
- C
Check how mealtime insulin and correction dosing should be adjusted under the orders and protocol.
- D
Increase glucose monitoring as directed by the clinical plan.
- E
Continue every insulin dose unchanged without checking the order or clinical plan.
To help reduce when transitioning from intravenous to subcutaneous insulin, give subcutaneous basal insulin about before stopping the infusion.
A nurse is checking the usual role of glargine when reviewing a patient’s insulin plan. Which description is accurate?
- A
Rapid-acting insulin often used for meal coverage.
- B
Long-acting basal insulin that generally has no pronounced peak.
- C
Intermediate-acting insulin with a noticeable peak, usually cloudy.
- D
Short-acting insulin generally given earlier before a meal than rapid-acting insulin.
Before discharging a patient who uses insulin, describe the key steps the care team should take to support safe insulin use at home.
During an insulin product check, which description best identifies NPH insulin?
- A
Rapid-acting; often used for meal coverage
- B
Intermediate-acting; has a noticeable peak and is usually cloudy
- C
Long-acting basal; generally has no pronounced peak
- D
Short-acting; generally given earlier before a meal than rapid-acting insulin
An insulin pen can be used for more than one patient if a new needle is attached for each patient.
- A
True
- B
False
What action must the nurse take before administering insulin when an order is incomplete or conflicting?
An order says “insulin 12 units subcutaneously,” but the available products are a U-100 vial and a U-500 pen. What is the safest next step?
- A
Use either product because both contain insulin.
- B
Give 12 units from the U-500 pen because the dose is written in units.
- C
Verify the exact insulin product and concentration against the order or with the prescriber.
- D
Convert 12 units to milliliters and administer from whichever product is available.
A patient’s prescribed rapid-acting insulin is due with lunch, but the glucose check is complete and the meal tray is delayed. What is the safest action?
- A
Give the full dose immediately so it is not late.
- B
Coordinate the dose with meal availability and follow the order and facility protocol; clarify if timing or intake is uncertain.
- C
Give the dose and ask the patient to wait for the meal.
- D
Replace the mealtime dose with long-acting insulin.
Using the prescribed transition protocol, how many hours before stopping an intravenous insulin infusion should subcutaneous basal insulin generally be given?